advertisement
Eye 67
Showing records 1 to 25 | Display all abstracts in Eye79712 Prospective analysis of the predictors of glaucoma following surgery for congenital and infantile cataract
Balekudaru S
Eye 2019; 33: 796-803
80051 Ocular abnormalities and complications in anterior megalophthalmos: a case series
Kumawat D
Eye 2019; 33: 826-832
79730 1-year outcomes of the Xen45 glaucoma implant
Smith M
Eye 2019; 33: 761-766
79389 Acute primary angle closure-treatment strategies, evidences and economical considerations
Chan PP
Eye 2019; 33: 110-119
79779 Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma
Aktaş Z
Eye 2019; 33: 668-673
80006 Non-physician grader reliability in measuring morphological features of the optic nerve head in stereo digital images
Addis V
Eye 2019; 33: 838-844
79888 Risk assessment of sudden visual loss following non-penetrating deep sclerectomy in severe and end-stage glaucoma
Leleu I
Eye 2019; 33: 902-909
79407 Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio
Dawson SR
Eye 2019; 33: 610-618
79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Lin C
Eye 2019; 33: 777-784
79802 Quality of life following surgery for congenital glaucoma: findings of the LVPEI congenital glaucoma registry
Gothwal VK
Eye 2019; 33: 659-667
79389 Acute primary angle closure-treatment strategies, evidences and economical considerations
Pang JC
Eye 2019; 33: 110-119
79730 1-year outcomes of the Xen45 glaucoma implant
Charles R
Eye 2019; 33: 761-766
79407 Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio
Linton E
Eye 2019; 33: 610-618
80051 Ocular abnormalities and complications in anterior megalophthalmos: a case series
Alam T
Eye 2019; 33: 826-832
79888 Risk assessment of sudden visual loss following non-penetrating deep sclerectomy in severe and end-stage glaucoma
Penaud B
Eye 2019; 33: 902-909
79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wu F
Eye 2019; 33: 777-784
79802 Quality of life following surgery for congenital glaucoma: findings of the LVPEI congenital glaucoma registry
Seelam B
Eye 2019; 33: 659-667
80006 Non-physician grader reliability in measuring morphological features of the optic nerve head in stereo digital images
Oyeniran E
Eye 2019; 33: 838-844
79712 Prospective analysis of the predictors of glaucoma following surgery for congenital and infantile cataract
Agarkar S
Eye 2019; 33: 796-803
79779 Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma
Özmen MC
Eye 2019; 33: 668-673
80006 Non-physician grader reliability in measuring morphological features of the optic nerve head in stereo digital images
Daniel E
Eye 2019; 33: 838-844
79779 Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma
Atalay HT
Eye 2019; 33: 668-673
79802 Quality of life following surgery for congenital glaucoma: findings of the LVPEI congenital glaucoma registry
Mandal AK
Eye 2019; 33: 659-667
79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Zheng T
Eye 2019; 33: 777-784
79888 Risk assessment of sudden visual loss following non-penetrating deep sclerectomy in severe and end-stage glaucoma
Blumen-Ohana E
Eye 2019; 33: 902-909
